e-learning
resources
Berlin 2001
Monday 24.09.2001
Exposure to allergens and chemicals: clincial and mechanistical studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants
W. Anees, V. Huggins, I. Pavord, A. S. Robertson, S. Burge (Birmingham, Leicester, United Kingdom)
Source:
Annual Congress 2001 - Exposure to allergens and chemicals: clincial and mechanistical studies
Session:
Exposure to allergens and chemicals: clincial and mechanistical studies
Session type:
Thematic Poster Session
Number:
1882
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Anees, V. Huggins, I. Pavord, A. S. Robertson, S. Burge (Birmingham, Leicester, United Kingdom). Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Eur Respir J 2001; 16: Suppl. 31, 1882
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Different level of GSNO(S-nitrosoglutathione) between eosinophilic bronchitits and asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009
Comparison between airway response to high versus low molecular weight agents in occupational asthma
Source: Annual Congress 2010 - Occupational asthma
Year: 2010
Persistence of the asthmatic response in two animal models with exposure to high and low molecular weight agents
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013
Comparative airway response to high- versus low-molecular weight agents in occupational asthma
Source: Eur Respir J 2009; 33: 734-739
Year: 2009
Occupational asthma and extrinsic allergic alveolitis: old conditions with many new causes
Source: International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease
Year: 2015
Definitions and types of work-related asthma: a nosological approach
Source: Eur Respir J 2003; 21: 706-712
Year: 2003
Occupational asthma induced by exposure to high and low molecular weight agents. Similarities and differences
Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis
Year: 2013
Anti-IgE as an alternative treatment for occupational asthma due to low molecular weight agents
Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Year: 2016
New-onset work-related airway symptoms in workers exposed to high molecular weight (HMW) agents are predicted by clinical markers of airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 509s
Year: 2001
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Rate of FEV1 decline in workers with eosinophilic and non-eosinophilic occupational asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 155s
Year: 2007
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Allergic and nonallergic factors in severe asthma
Source: Eur Respir Mon 2011; 51: 107-119
Year: 2011
Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept